Will Fractyl be Successful in Eliminating the Need for Daily Insulin?

[cafead]

via The Lexington, MA-based company has enrolled the first patient in a pivotal study of its Revita DMR treatment. Fractyl said Revita uses thermal ablation to ablate a portion of the duodenum mucosa, which if proven, could improve glucose control in patients struggling to manage the disease.

article source